Rotavirus Vaccine Significantly Reduces Mortality from Rotavirus-Associated Acute Gastroenteritis in Children Under 5: Insights from the MNSSTER-V Global Dataset

Rotavirus Vaccine Significantly Reduces Mortality from Rotavirus-Associated Acute Gastroenteritis in Children Under 5: Insights from the MNSSTER-V Global Dataset

A pooled analysis from 22 countries demonstrates that rotavirus vaccination is highly effective in preventing rotavirus-positive acute gastroenteritis deaths in children under five, underscoring the vaccine's critical role in reducing childhood diarrheal mortality worldwide.
Neurological Effects and Safety of Encapsulated Dexamethasone Sodium Phosphate in Pediatric Ataxia Telangiectasia: Insights from the NEAT Phase 3 Trial

Neurological Effects and Safety of Encapsulated Dexamethasone Sodium Phosphate in Pediatric Ataxia Telangiectasia: Insights from the NEAT Phase 3 Trial

The NEAT phase 3 trial evaluated erythrocyte-encapsulated dexamethasone sodium phosphate in children with ataxia telangiectasia aged 6–9 years, confirming safety but failing to demonstrate statistically significant neurological improvement over placebo.
Neurodevelopmental Outcomes of Anti-VEGF versus Laser Photocoagulation for Retinopathy of Prematurity: Insights from a Comprehensive Review by the American Academy of Ophthalmology

Neurodevelopmental Outcomes of Anti-VEGF versus Laser Photocoagulation for Retinopathy of Prematurity: Insights from a Comprehensive Review by the American Academy of Ophthalmology

This review synthesizes current evidence on neurodevelopmental outcomes after treating retinopathy of prematurity with anti-VEGF injections versus laser photocoagulation, finding no significant differences in long-term cognitive or developmental effects.